All Italy articles
-
ResearchThriving wine trade in Islamic Sicily revealed by the chemistry of its pottery
A new method for determining if pottery containers held wine or other grape products could help archaeologist chart the use of the ancient drink
-
ResearchSearching for superconductors with supercomputers
What if most materials are superconductors under the right conditions, wonders José Flores-Livas
-
OpinionChemists amid coronavirus: Akash Deep Biswas
A young computational chemist from India, working to finish his PhD in Italy, is getting media attention for his social action during the pandemic
-
NewsItalian researchers fear long-lasting harm to science from coronavirus lockdown
With the entire population isolated and universities closed research has been severely curtailed
-
OpinionHow old is the Turin Shroud?
New evidence has reopened the debate on radiocarbon dating of the relic
-
OpinionCollaborative atmospheres
A project in three European countries is alerting rural communities to ozone pollution
-
PodcastLevulinic acid
How one footballer's climate concerns led to the creation of a green chemistry company: the story of Mathieu Flamini, GFBiochemicals and levulinic acid.
-
OpinionDeath of a Renaissance Man
Two unsolved deaths in Medici Florence may finally have a solution
-
CareersFashioning a career in Lombardy
One of the largest chemical industries in Europe is ready to entice you to enjoy la dolce vita
-
OpinionThe forgotten father of chemistry?
New evidence reveals how a 16th century Italian physician shaped modern science
-
NewsItaly to plough €400 million into basic research fund
Reserves from the heavily criticised Italian and Institute of Techology will be redirected
-
NewsItalian unions denounce unequal R&D investment
Universities being left out in the cold by funding decisions
-
-
NewsResearchers call on EU to save Italian research
Online petition demands EU pull brakes on research funding cuts in Italy
-
Business
Drug companies rapped for anticompetitive behaviour
Italian authorities demand €1.2 billion in damages from Roche, Novartis and Pfizer